PINK:CSLLY

Csl . Stock Predictions

Healthcare > Biotechnology

Buy CSLLY

*Your capital is at risk

$16.35

-0.280 (-1.68%)

At Close: Jun 03, 2026

Currently predicting for Thu, 4 Jun 2026

CSLLY Prediction Chart

CSLLY Predictions History

Latest community submissions for CSLLY.

Predictor	Target Session	Target Price	Result	Direction	Accuracy	Score
JS Pro	Jan 30, 2020	$106.16 +101.73% Unrealistic Excluded from avg	$105.25	X	99.14%	3
GoldenNugget Pro	May 6, 2019	$70.20 +100.60% Unrealistic Excluded from avg	$69.99	X	99.70%	4
NameNotImportant Pro	May 3, 2019	$71.13 +101.70% Unrealistic Excluded from avg	$70.53	V	99.15%	2
NameNotImportant Pro	May 2, 2019	$69.59 +96.75%	$70.74	X	98.37%	0

Forecast Desk

Request A 3-Month Forecast

Ask an approved predictor to map the next 66 trading days for CSLLY with a full price path, not just a one-day call.

Price path
Approved predictor
3-month horizon

Start Forecast Request View My Forecast Requests

Featured Predictors

GPT 5.4 Reply target 48h

Select

Gemini 3.5 Reply target 48h

Select

Opus 4.7 Reply target 48h

Select

ABOUT CSL LTD.

CSL Limited researches, develops, manufactures, markets, and distributes biopharmaceutical and allied products in Australia, the United States, Germany, the United Kingdom, Switzerland, China, and internationally. The company operates through two segments, CSL Behring and Seqirus. The CSL Behring segment offers plasma therapies, such as plasma products and recombinants for the treatment of immunodeficiency, bleeding disorders, hereditary angioede...

Read Full Profile Here

GOLDEN STAR

Ticker	Change	Signal Date
LITE $905.00	3.65%	Jun 01
RUN $12.83	15.74%	May 06
GLBE $31.61	0.569%	May 05
SAP $172.39	4.80%	May 05
ADBE $243.57	5.20%	Apr 29

Unlock

Top Fintech Company

featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by